Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits.
Damona Pharmaceuticals has raised $5.5M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Damona Pharmaceuticals's investors include Lumira Ventures, CAMH, Noetic Fund, Toronto Innovation Acceleration Partners.
Damona Pharmaceuticals is headquartered in Toronto, Canada.
Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits.
Damona Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Damona Pharmaceuticals — Funding & Investors." VCBacked, September 26, 2022, https://www.vcbacked.co/company/damona-pharmaceuticals. Accessed October 31, 2026.
VCBacked. (2022). Damona Pharmaceuticals — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/damona-pharmaceuticals
{{cite web |title=Damona Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/damona-pharmaceuticals |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated